Access cutting-edge acneiform rash treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access acneiform rash specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acneiform rash treatment provided free
The goal of this clinical trial is to learn about HT-001 Topical Gel for treatment of EGFR inhibitor-induced skin toxicities. The main questions it aims to answer are: * Determine the therapeutic effect of HT-001 for treatment of patients who develop acneiform rash undergoing Epidermal Growth Factor inhibitor (EGFRI) therapy using the acneiform rash investigator's global assessment scale \[ARIGA\] * Evaluate the safety of HT-001 during treatment Participants will apply HT-001 Gel once per day
Sponsor: Hoth Therapeutics, Inc.
Check if you qualify for this acneiform rash clinical trial in Boston, MA
If you're searching for acneiform rash treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acneiform rash specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.